In plain words
Small studies gave people NMN for weeks to months and tested grip, leg or chair-stand strength. Most found no difference from people taking a placebo or only exercising. One trial in healthy older men found a partial gain in grip.
The short answer
Two of the three randomized trials found no difference: Kim (2022) in 108 people at 250 mg a day for 12 weeks, and Liao (2021) in 48 exercisers at 300 to 1,200 mg a day for 6 weeks. Igarashi (2022) found partly better grip in older men at 250 mg a day for 12 weeks; the ledger has no n. A 24-week placebo comparison in 14 people at 250 mg a day found no difference. A review describes a 4-week trial of 2,000 mg a day in 30 people with no gain in maximum strength. Certainty is low, because the studies are small and short.
Where the evidence sits
Strength improved
No difference
■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data
Who says what
| Source | Finding | Design | People | Dose and length | Funding and independence |
|---|---|---|---|---|---|
| Igarashi et al., 2022 | Grip partly better | Randomized trial | Older men, n not in ledger | 250 mg/day, 12 weeks | Not in ledger |
| Kim et al., 2022 | No grip change | Randomized trial with placebo groups | 108 | 250 mg/day, 12 weeks | Not in ledger |
| Liao et al., 2021 | No gain over exercise alone | Randomized trial | 48 | 300 to 1,200 mg/day, 6 weeks | Not in ledger |
| Akasaka et al., 2022 | No grip difference | NMN versus placebo study | 14 | 250 mg/day, 24 weeks | Not in ledger |
| Prokopidis et al., 2025 | No pooled grip difference | Meta-analysis, may include trials above | Not in ledger | Not in ledger | Not in ledger |
| Wen et al., 2024 | Nonsignificant improvement | Review, may include trials above | 437 | 150 to 1,200 mg/day, 4 to 12 weeks | Not in ledger |
| The Conversation, 2026 | No convincing evidence | Article summarising reviews | None | None | Kingston University authors |
Grip partly better
No grip change
No gain over exercise alone
No grip difference
No pooled grip difference
Nonsignificant improvement
No convincing evidence
Which trial found a gain?
Igarashi (2022) gave healthy older men 250 mg of NMN a day for 12 weeks and reported better left-hand grip; the ledger has no n for the trial:
These findings indicate that the chronic oral supplementation of NMN partly improved the muscle strength and performance in healthy older men, although NMN did not affect the skeletal muscle mass.
Did other studies find the same?
Kim (2022) gave 108 people 250 mg a day for 12 weeks: grip did not change significantly, and on five chair stands the afternoon NMN group had the largest before-after effect (d = 0.72), though all four groups improved, placebo included:
The post hoc analysis revealed significantly improved 5-STS in Post compared with Pre in all groups.
Liao (2021) found no difference in grip, push-ups or sit-and-reach when 48 exercisers added 300, 600 or 1,200 mg a day for 6 weeks. Akasaka (2022) found grip no different between NMN and placebo in 14 people at 250 mg a day for 24 weeks.
What do the reviews add?
Prokopidis (2025) describes a trial of 30 people at 2,000 mg a day for 4 weeks with no change in chest press or leg press maximum, and one difference:
a statistical change on leg press to failure was demonstrated, for which, the placebo group performed more repetitions (p = 0.02)
Prokopidis also pooled grip data and found no difference, a pooled estimate that may include the trials above. Wen (2024), reviewing 10 trials in 437 people (150 to 1,200 mg a day, 4 to 12 weeks) that may include the trials above, found NMN was associated with a nonsignificant improvement in strength.
Why the sources disagree
Dose ran from 250 to 2,000 mg a day and length from 4 to 24 weeks, in healthy older men, exercisers and other adults, tested by grip, chair stands or presses. Igarashi's gain was in the left hand. Kim's chair-stand rise appeared in the placebo groups too, so change from baseline and difference from placebo can point different ways. The ledger has no funding details for any study.
What would settle it
An independent randomized trial of 250 mg and 1,000 mg of NMN a day against placebo for 24 weeks in at least 200 older adults, with grip in both hands and leg press as pre-registered outcomes. A matching result from a second research group would raise certainty from low to moderate.
How this page was made
The 7 sources are four studies that measured strength themselves, two systematic reviews (Prokopidis, with a meta-analysis giving a pooled estimate that may include the trials above, and Wen) and an article in The Conversation, found by a literature search. Every claim was copied word for word into the Longevity Circle ledger and checked against the original text, and a person approved each one. Certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.
Changelog: 23 Sep 2026, first version, 7 sources.
